A DNA methylation classifier of cervical precancer based on human papillomavirus and human genes
1425 - 1432
INTERNATIONAL JOURNAL OF CANCER
MetadataShow full item record
AuthorsBrentnall, AR; Vasiljevic, N; Scibior-Bentkowska, D; Cadman, L; Austin, J; Szarewski, A; Cuzick, J; Lorincz, AT
Showing items related by title, author, creator and subject.
Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial. Huh, WK; Joura, EA; Giuliano, AR; Iversen, O-E; de Andrade, RP; Ault, KA; Bartholomew, D; Cestero, RM; Fedrizzi, EN; Hirschberg, AL (2017-11-11)BACKGROUND: Primary analyses of a study in young women aged 16-26 years showed efficacy of the nine-valent human papillomavirus (9vHPV; HPV 6, 11, 16, 18, 31, 33, 45, 52, and 58) vaccine against infections and disease ...
Lorincz, A; Castanon, A; Wey Lim, AW; Sasieni, P (2013-09)Human papillomavirus testing has been shown to be far more sensitive and robust in detecting cervical intraepithelial neoplasia 2 and above (and cervical intraepithelial neoplasia 3 and above) for cervical screening than ...
The Role of Human Papillomaviruses and Polyomaviruses in BRAF-Inhibitor Induced Cutaneous Squamous Cell Carcinoma and Benign Squamoproliferative Lesions. Purdie, KJ; Proby, CM; Rizvi, H; Griffin, H; Doorbar, J; Sommerlad, M; Feltkamp, MC; der Meijden, EV; Inman, GJ; South, AP (2018)Background: Human papillomavirus (HPV) has long been proposed as a cofactor in the pathogenesis of cutaneous squamous cell carcinoma (cSCC). More recently, the striking clinico-pathological features of cSCCs that complicate ...